Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein

被引:6
作者
Mori, Mattia [1 ]
Ciaco, Stefano [1 ,2 ]
Mely, Yves [2 ]
Karioti, Anastasia [3 ]
机构
[1] Univ Siena, Dept Biotechnol Chem & Pharm, Via Aldo Moro 2, I-53100 Siena, Italy
[2] Univ Strasbourg, Fac Pharm, UMR CNRS 7021, Lab Bioimagerie & Pathol, 74 Route Rhin, F-67401 Illkirch Graffenstaden, France
[3] Aristotle Univ Thessaloniki, Sch Pharm, Lab Pharmacognosy, Thessaloniki 54124, Greece
来源
MOLECULES | 2020年 / 25卷 / 22期
关键词
lithospermic acid; nucleocapsid protein; catechol; natural products; HIV; molecular modeling; fluorescence-based assays; STRUCTURAL-CHARACTERIZATION; IDENTIFICATION; COMPLEX; POTENT; INTEGRATION; TARGET; NCP7;
D O I
10.3390/molecules25225434
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The HIV-1 nucleocapsid protein (NC) is a desirable target in antiretroviral therapy due to its high conservation among HIV-1 strains, and to its multiple and crucial roles in the HIV-1 replication cycle. Natural products represent a valuable source of NC inhibitors, with the catechol group being a privileged scaffold in NC inhibition. By coupling molecular modeling with NMR spectroscopy and fluorescence-based assays, we disclosed lithospermic acid, a catechol derivative extracted from Salvia miltiorrhizza, as a potent and chemically stable non-covalent inhibitor of the NC. Being different from other catechol derivative reported so far, lithospermic acid does not undergo spontaneous oxidation in physiological conditions, thus becoming a profitable starting point for the development of efficient NC inhibitors.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Synthesis and HIV-1 Inhibitory Activities of Dicaffeoyl and Digalloyl Esters of Quinic Acid Derivatives
    Junior, C. O. R.
    Verde, S. C.
    Rezende, C. A. M.
    Caneschi, W.
    Couri, M. R. C.
    McDougall, B. R.
    Robinson, W. E., Jr.
    de Almeida, M. V.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (05) : 724 - 733
  • [42] Zinc finger function of HIV-1 nucleocapsid protein is required for removal of 5′-terminal genomic RNA fragments: A paradigm for RNA removal reactions in HIV-1 reverse transcription
    Hergott, Christopher B.
    Mitra, Mithun
    Guo, Jianhui
    Wu, Tiyun
    Miller, Jennifer T.
    Iwatani, Yasumasa
    Gorelick, Robert J.
    Levin, Judith G.
    VIRUS RESEARCH, 2013, 171 (02) : 346 - 355
  • [43] HIV-1 nucleocapsid protein as a nucleic acid chaperone: Spectroscopic study of its helix-destabilizing properties, structural binding specificity, and annealing activity
    Urbaneja, MA
    Wu, M
    Casas-Finet, JR
    Karpel, RL
    JOURNAL OF MOLECULAR BIOLOGY, 2002, 318 (03) : 749 - 764
  • [44] Nucleic acid conformational changes essential for HIV-1 nucleocapsid protein-mediated inhibition of self-priming in minus-strand transfer
    Hong, MK
    Harbron, EJ
    O'Connor, DB
    Guo, JH
    Barbara, PF
    Levin, JG
    Musier-Forsyth, K
    JOURNAL OF MOLECULAR BIOLOGY, 2003, 325 (01) : 1 - 10
  • [45] The Cellular Protein Lyric Interacts with HIV-1 Gag
    Engeland, Christine E.
    Oberwinkler, Heike
    Schuemann, Michael
    Krause, Eberhard
    Mueller, Gerd A.
    Kraeusslich, Hans-Georg
    JOURNAL OF VIROLOGY, 2011, 85 (24) : 13322 - 13332
  • [46] Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
    Sosic, Alice
    Cappellini, Marta
    Scalabrin, Matteo
    Gatto, Barbara
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2015, (95):
  • [47] A specific protein disorder catalyzer of HIV-1 Nef
    Lugari, Adrien
    Breuer, Sebastian
    Coursindel, Thibault
    Opi, Sandrine
    Restouin, Audrey
    Shi, Xiaoli
    Nazabal, Alexis
    Torbett, Bruce E.
    Martinez, Jean
    Collette, Yves
    Parrot, Isabelle
    Arold, Stefan T.
    Morelli, Xavier
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (24) : 7401 - 7406
  • [48] Inhibitory Effects of HIV-2 Vpx on Replication of HIV-1
    Mahdi, Mohamed
    Szojka, Zsofia
    Motyan, Janos Andras
    Tozser, Jozsef
    JOURNAL OF VIROLOGY, 2018, 92 (14)
  • [49] Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition
    Rugeles, MT
    Trubey, CA
    Bedoya, VI
    Pinto, LA
    Oppenheim, JJ
    Rybak, SA
    Shearer, GM
    AIDS, 2003, 17 (04) : 481 - 486
  • [50] Long-Acting HIV-1 Fusion Inhibitory Peptides and their Mechanisms of Action
    Wang, Chen
    Cheng, Shuihong
    Zhang, Yuanyuan
    Ding, Yibo
    Chong, Huihui
    Xing, Hui
    Jiang, Shibo
    Li, Xuebing
    Ma, Liying
    VIRUSES-BASEL, 2019, 11 (09):